Last reviewed · How we verify

NCT03526406

Investigation of the Acute and Chronic Cognitive and Mood Effects of CP9700 in Humans

Completed NA Last updated 20 August 2020
What this trial tests

NA trial testing CP9700 in Cognitive Function in 60 participants. Completed in 28 February 2019.

Timeline
20 November 2017
Primary endpoint
28 February 2019
28 February 2019

Quick facts

Lead sponsorUniversity of Reading
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment60
Start date20 November 2017
Primary completion28 February 2019
Estimated completion28 February 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Reading

Who can join

Adults 21 to 30, any sex, with Cognitive Function or Mood. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This acute-on-chronic study will examine the effectiveness of CP9700 for improving cognitive performance and mood in healthy young adults. CP9700 is a mix of highly purified grape seed-derived polyphenolic extracts from Vitis vinifera produced by Polyphenolics Inc. (Madera, CA, USA). The polyphenolic component of the product is comprised entirely of catechin and epicatechin, derivatives of catechin and epicatechin (e.g.,epicatechin gallate), and proanthocyanidins. We will perform a randomised, double-blind, parallel-groups human intervention trial using CP9700 and a well characterised sugar-matched placebo to investigate changes in cognitive performance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases.
    Marino A, Battaglini M, Moles N, Ciofani G. · · 2022 · cited 58× · PMID 35936442 · DOI 10.1021/acsomega.2c03291

Verify or expand the search:

Other recruiting trials for Cognitive Function

Currently open trials in the same condition.

Other University of Reading trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03526406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing